Cancer still remains a leading cause of death worldwide. In fact, it continues to rise-especially in emerging economies like India. The advanced treatments such as biologics transform oncology care with high cost, and it is still challenging for many patients …
So far, with advancements and technological developments, the Indian pharmaceutical sector has established itself as one of the global leaders in generic drug manufacturing. Apart from its various segments-oncology industry has also recorded rising demand for affordable cancer medications. And …
Precisely, the oncology CDMO-drug development market is today one of the fastest growing segments in the pharma sector. From advanced formulations that are needed in complexities and sensitivity, pharma companies are increasingly turning to specialized partners for Oncology CDMOs (Contract …
Cancer is increasing—19.3 million new diagnoses and almost 10 million fatalities were recorded worldwide in 2020, states the WHO. That figure can only increase, fueling an immediate need for innovative oncology pharmaceutical companies to develop breakthrough therapies. For many pharmaceutical …
Envision a market so profitable and rapidly expanding that even the largest oncology pharmaceutical companies have difficulty keeping pace. That’s precisely what’s transpiring in oncology. Spending on oncology drugs globally surged to $223 billion in 2023 alone—a whopping $25 billion …
If you’re looking for the best CMOs working in oncology, you likely have urgent questions—Which CMO guarantees the maximal level of compliance? Who can ably manage HPAPIs? How do you mitigate the risks of production while ensuring deadlines are met? …
Cancer cases are on the rise worldwide, and India is at the epicentre of this growing crisis. In recent estimates, India has more than 1.5 million cancer cases diagnosed every year, expected to rise by 12% by 2025. The demand …
Small-medium enterprises in the pharmaceutics sectors play a major role in innovation within the industry. However, the financial constraints are generally so limiting that most of these organisations have not really been able to scale up their production and license …
India’s oncology pharma market, one of the most significant in global anti-cancer treatment, is thought to be suffering due to mighty supply chain challenges. Approximately 50 percent of all oncology drugs in India are brought in from other countries, with …
Choosing a pharmaceutical company that produces high-quality oncology medicines is crucial, especially as the demand for cancer treatment surges. In India, one in nine individuals is diagnosed with cancer in their lifetime, with each case presenting unique challenges. Meeting the …